
Annual report 2025
added 03-12-2026
Health Catalyst Net Debt 2011-2026 | HCAT
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Health Catalyst
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105 M | -94.9 M | 125 M | 114 M | -8.86 M | 79.7 M | 240 M | -1.52 M | -10.4 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 240 M | -94.9 M | 60.9 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Health information services industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-12 M | - | 0.29 % | $ 206 M | ||
|
Phreesia
PHR
|
-84 M | $ 11.28 | - | $ 615 M | ||
|
Change Healthcare
CHNG
|
4.65 B | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
720 M | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
-178 M | $ 5.63 | -2.26 % | $ 90.3 M | ||
|
Computer Programs and Systems
CPSI
|
193 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
863 M | - | - | $ 2.94 B | ||
|
Schrödinger
SDGR
|
-121 M | $ 11.4 | -1.47 % | $ 837 M | ||
|
iCAD
ICAD
|
-16.8 M | - | - | $ 102 M | ||
|
Castlight Health, Inc.
CSLT
|
-34.4 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
67.9 M | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
763 M | - | - | $ 6.37 B | ||
|
Teladoc Health
TDOC
|
225 M | $ 5.57 | 2.77 % | $ 982 M | ||
|
NextGen Healthcare
NXGN
|
-42.1 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
-41.2 M | - | - | $ 3.37 B | ||
|
Premier
PINC
|
128 M | - | - | $ 2.33 B | ||
|
Omnicell
OMCL
|
-327 M | $ 34.94 | 1.39 % | $ 1.61 B | ||
|
OptimizeRx Corporation
OPRX
|
20.6 M | $ 7.18 | 5.9 % | $ 123 M | ||
|
Evolent Health
EVH
|
232 M | $ 2.27 | 0.89 % | $ 213 M | ||
|
MTBC
MTBC
|
-1.02 M | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
44 M | $ 2.06 | 0.98 % | $ 795 M | ||
|
SCWorx Corp.
WORX
|
-376 K | $ 0.13 | 1.5 % | $ 190 K | ||
|
Signify Health
SGFY
|
-126 M | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
638 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
13.7 M | - | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
181 M | - | -10.39 % | $ 886 M | ||
|
NantHealth
NH
|
4.4 M | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
648 M | $ 82.47 | 0.45 % | $ 7.1 B | ||
|
HealthStream
HSTM
|
-39.3 M | $ 21.23 | 1.24 % | $ 645 M | ||
|
10x Genomics
TXG
|
-264 M | $ 20.91 | 5.55 % | $ 2.45 B | ||
|
Streamline Health Solutions
STRM
|
2.4 M | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-54.5 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
-143 M | $ 17.75 | -1.66 % | $ 1.52 B | ||
|
So-Young International
SY
|
-563 M | $ 3.19 | 9.62 % | $ 253 M | ||
|
Veeva Systems
VEEV
|
-1.33 B | $ 178.11 | -0.56 % | $ 29.2 B |